In November 2018, my healthy-looking father was sent to the emergency room for excruciating chest pains. During his visit, the doctors told us he needed an emergency heart operation. We were told the procedure was high-risk with an extremely low chance of survival. My father survived the operation; however, he did not survive the recovery process.
He passed away on December 2, 2018.
After my father’s passing, we learned that he had a rare connective tissue disease called Marfan syndrome. This genetic disorder produces abnormalities in the connective tissue of the body and can result in many defects in the chambers of the heart and weakening/stretching of the aorta (such as aortic aneurysm, aortic dissection, and mitral valve prolapse). My father had no warning signs or symptoms that would have alerted him of this disease. This disease could have been detected through genetic testing.
This experience catalyzed the creation of Innovative Gx Laboratories. Our mission is to improve patient care by making personalized solutions available to all. Ideally, to create a world where no one has to lose a loved one when it could have been prevented by receiving a genetic test.